PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gut hormone test predicts individual efficacy of gastric bypass

2013-11-08
(Press-News.org) Contact information: Matthias Tschöp
matthias.tschoep@helmholtz-muenchen.de
49-893-187-2103
Helmholtz Zentrum München - German Research Center for Environmental Health
Gut hormone test predicts individual efficacy of gastric bypass The gastric bypass is one of the most commonly performed surgical procedures in the treatment of obesity. In most patients, it quickly produces substantial body weight loss. Moreover, even before the weight loss, the procedure leads to improved glucose tolerance. However, these metabolic improvements vary considerably from patient to patient.

A hormone test may be able to predict the extent of metabolic improvement caused by the gastric bypass. These are the results of a study on a rodent model conducted by Prof. Dr. Matthias Tschöp and his colleagues from the Institute of Diabetes and Obesity (IDO), Helmholtz Diabetes Center at Helmholtz Zentrum München together with a team of researchers led by Dr. Kirk Habegger at the Metabolic Disease Institute of the University of Cincinnati.

After gastric bypass surgery, the concentration of the gut hormone GLP-1 (glucagon-like peptide 1) in the blood rises significantly. GLP-1 increases insulin secretion and contributes to improved blood glucose levels and blood lipids. As the rat studies by the Tschöp and Habegger research teams showed, GLP-1 responsiveness varied considerably with regard to glucose metabolism. More importantly, the more responsive the animals were to GLP-1, the greater the efficacy of the gastric bypass turned out to be regarding glucose metabolism improvements.

Thus, the responsiveness to GLP-1 could be a key indicator for the success of the gastric bypass. "If our results are confirmed in clinical trials with patients, the hormone response could be tested before the planned surgery and surgeons would be able to predict how much an individual patient's glucose metabolism would benefit," said Tschöp. "This will contribute to the development of personalized therapies for type 2 diabetes and obesity. For surgical procedures such as gastric bypass this is particularly compelling because such operations are complex and cannot be easily reversed."

The numerous secondary diseases related to excess weight and obesity, such as type 2 diabetes, are among the most common diseases in Germany. These diseases are the focus of research at Helmholtz Zentrum München, a partner in the German Center for Diabetes Research (DZD).

### Further Information

Original publikation: Habegger, KM et al (2013). GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats, Diabetes, doi: 10.2337/db13-0511 Link to publication: http://diabetes.diabetesjournals.org/content/early/2013/10/03/db13-0511.abstract

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,100 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 34,000 staff members.

The German Center for Diabetes Research (DZD) brings together experts in the field of diabetes research and interlinks basic research, epidemiology and clinical applications. Members are the German Diabetes Center in Düsseldorf, the German Institute of Human Nutrition (DIfE) in Potsdam-Rehbrücke, Helmholtz Zentrum München – German Research Center for Environmental Health, the Paul Langerhans Institutes of the University Hospital Carl Gustav Carus in Dresden and the University of Tübingen, as well as the Gottfried Wilhelm Leibniz Association and the Helmholtz Association of German Research Centres. The objective of the DZD is to find answers to open questions in diabetes research by means of a novel, integrative research approach and to make a significant contribution to improving the prevention, diagnosis and treatment of diabetes mellitus.

The Institute of Diabetes and Obesity (IDO) studies the diseases of the metabolic syndrome by means of systems biological and translational approaches on the basis of cellular systems, genetically modified mouse models and clinical intervention studies. It seeks to discover new signaling pathways in order to develop innovative therapeutic approaches for the personalized prevention and treatment of obesity, diabetes and their concomitant diseases. IDO is part of the Helmholtz Diabetes Center (HDC).

Contact for the media

Communication Department, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany - Phone: +49-89-3187-2238 - Fax: +49-89-3187-3324 - Email: presse@helmholtz-muenchen.de

Specialist contact Prof. Matthias Tschöp, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Diabetes and Obesity, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany - Phone: +49-89-3187-2103 - Email: matthias.tschoep@helmholtz-muenchen.de


ELSE PRESS RELEASES FROM THIS DATE:

A*STAR scientists uncover potential drug target to nip cancer in the bud

2013-11-08
A*STAR scientists uncover potential drug target to nip cancer in the bud This discovery could eradicate cancers more effectively and prevent relapses 1. Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, ...

Novel LEDs pave the way to cheaper displays

2013-11-08
Novel LEDs pave the way to cheaper displays Applications in smart phones or luminescent bathroom tiles conceivable / Collaboration of Bonn University, Regensburg University, the University of Utah and MIT OLEDs are already used in the displays of smart phones ...

New test for patients with sore throats cuts antibiotic use by nearly a third

2013-11-08
New test for patients with sore throats cuts antibiotic use by nearly a third A new 'clinical score' test for patients with sore throats could reduce the amount of antibiotics prescribed and result in patients feeling better more quickly, research in the British ...

Mother's immunosuppressive medications not likely to put fetus at risk

2013-11-08
Mother's immunosuppressive medications not likely to put fetus at risk Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased ...

Study shows veterans psychologically impacted by Boston Marathon Bombing

2013-11-08
Study shows veterans psychologically impacted by Boston Marathon Bombing (Boston) - According to a new study, many Boston-area military veterans diagnosed with post-traumatic stress disorder (PTSD) experienced flashbacks, unwanted memories and other psychological ...

Safe long term storage of CO2 is possible

2013-11-08
Safe long term storage of CO2 is possible Conclusion of an international project for the geological storage of carbon dioxide Potsdam, 07.11.2013 | At the final conference of the EU project CO2CARE - CO2 Site Closure Assessment Research ...

In animal study, 'cold turkey' withdrawal from drugs triggers mental decline

2013-11-08
In animal study, 'cold turkey' withdrawal from drugs triggers mental decline SAN DIEGO – Can quitting drugs without treatment trigger a decline in mental health? That appears to be the case in an animal model of morphine addiction. Georgetown University Medical ...

NASA sees Super-Typhoon Haiyan maintain strength crossing Philippines

2013-11-08
NASA sees Super-Typhoon Haiyan maintain strength crossing Philippines Super-Typhoon Haiyan slammed into the eastern Philippines as the strongest tropical cyclone of the year, and today, Nov. 8, is exiting the country and moving into the South China Sea. NASA's Aqua ...

Drug may guard against periodontitis, and related chronic diseases

2013-11-08
Drug may guard against periodontitis, and related chronic diseases WASHINGTON, DC – November 7, 2013 – A drug currently used to treat intestinal worms could protect people from periodontitis, an advanced gum disease, which untreated can erode the structures—including ...

A new scorpion species from ancient Lycia

2013-11-08
A new scorpion species from ancient Lycia Scientists discover and describe a new species of scorpion, Euscorpius lycius, coming from the area of ancient Lycia, nowadays the regions of the Muğla and Antalya Provinces in Southwestern Turkey. With the new discovery, ...

LAST 30 PRESS RELEASES:

Improving care for life-threatening blood clots

Yonsei University develops a new era of high-voltage solid-state batteries

Underweight and unbalanced: Gut microbial diversity in underweight Japanese women

Astringent, sharper mind: Flavanols trigger brain activity for memory and stress response

New editorial urges clinicians to address sex-based disparities in sepsis treatment

Researchers at MIT develop new nanoparticles that stimulate the immune system to attack ovarian tumors

Opening the door to a vaccine for multiple childhood infections

New clue to ALS and FTD: Faulty protein disrupts brain’s ‘brake’ system

Detailed map of US air-conditioning usage shows who can beat the heat — and who can’t

An electronic fiber for stretchable sensing

New image captures spooky bat signal in the sky

Cobalt single atom-phosphate functionalized reduced graphene oxide/perylenetetracarboxylic acid nanosheet heterojunctions for efficiently photocatalytic H2O2 production

World-first study shows Australian marsupials contaminated with harmful ‘forever chemicals’

Unlocking the brain’s hidden drainage system

Enhancing smoking cessation treatment for people living with HIV

Research spotlight: Mapping how gut neurons respond to bacteria, parasites and food allergy

Gordon and Betty Moore Foundation Experimental Physics Investigators awards to UCSB experimentalists opens the door to new insights and innovations

Meerkats get health benefit from mob membership

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

How a chorus of synchronized frequencies helps you digest your food

UAlbany researcher partners on $1.2 million NSF grant to explore tropical monsoon rainfall patterns

Checkup time for Fido? Wait might be longer in the country

Genetic variation impact scores: A new tool for earlier heart disease detection

The Lundquist Institute awarded $9 million to launch Community Center of Excellence for Regenerative Medicine

'Really bizarre and exciting': The quantum oscillations are coming from inside

Is AI becoming selfish?

New molten salt method gives old lithium batteries a second life

Leg, foot amputations increased 65% in Illinois hospitals between 2016-2023

Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer

National summit of experts charts unprecedented roadmap to reduce harms from firearms in new ways

[Press-News.org] Gut hormone test predicts individual efficacy of gastric bypass